30 related articles for article (PubMed ID: 16092077)
1. Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes.
Michael E; Malecela MN; Zervos M; Kazura JW
PLoS One; 2008 Aug; 3(8):e2936. PubMed ID: 18698350
[TBL] [Abstract][Full Text] [Related]
2. A regression spline model for developmental toxicity data.
Hunt DL; Li CS
Toxicol Sci; 2006 Jul; 92(1):329-34. PubMed ID: 16624852
[TBL] [Abstract][Full Text] [Related]
3. A shared response model for clustered binary data in developmental toxicity studies.
Pang Z; Kuk AY
Biometrics; 2005 Dec; 61(4):1076-84. PubMed ID: 16401281
[TBL] [Abstract][Full Text] [Related]
4. A parametric model for detecting hormetic effects in developmental toxicity studies.
Hunt DL; Bowman D
Risk Anal; 2004 Feb; 24(1):65-72. PubMed ID: 15028001
[TBL] [Abstract][Full Text] [Related]
5. The impact of litter effects on dose-response modeling in teratology.
Kupper LL; Portier C; Hogan MD; Yamamoto E
Biometrics; 1986 Mar; 42(1):85-98. PubMed ID: 3719065
[TBL] [Abstract][Full Text] [Related]
6. Using historical controls in the analysis of developmental toxicity data.
Ryan L
Biometrics; 1993 Dec; 49(4):1126-35. PubMed ID: 8117906
[TBL] [Abstract][Full Text] [Related]
7. A new threshold dose-response model including random effects for data from developmental toxicity studies.
Hunt DL; Rai SN
J Appl Toxicol; 2005; 25(5):435-9. PubMed ID: 16092077
[TBL] [Abstract][Full Text] [Related]
8. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and interpretation of maternal toxicity in Segment II studies: issues, some answers, and data needs.
Rogers JM; Chernoff N; Keen CL; Daston GP
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):367-74. PubMed ID: 15982694
[TBL] [Abstract][Full Text] [Related]
11. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
12. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
Jonker DM; Voskuyl RA; Danhof M
Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
